Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.
Quick Stats
Feb 03, 202653.0
AI Score
HOLD1.36
Volume Ratio
Feb 04, 2026
Next Earnings
15
+ve Days (30d)
14
-ve Days (30d)
CAI Stock Summary
Last updated Feb 03, 2026
CAI is currently trading at $23.2, positioned below its 200-day moving average of $None, suggesting bearish momentum. The stock has a 52-week range of $22.55 to $42.5.
Technical Analysis: The 50-day moving average stands at $26.58, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 33.94, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.025, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates CAI at 53.0/100 with a HOLD recommendation.
CAI (Caris Life Sciences, Inc. Common Stock) Indicators
Last updated Feb 03, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 33.94 |
| CMF (20) | -0.025 |
| ROC (10) | -11.686 |
| ADX (14) | 23.887 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.899 |
| AROONOSC (14) | -78.571 |
| WILLAMS %R (14) | -86.402 |
| MFI (14) | 48.131 |
CAI Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
CAI Price vs Max Options Open Interest
CAI Max Change In Options Open Interest
CAI Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CAI Daily Out of Money Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CAI Daily In the Money Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CAI Most Active Options by Volume(near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Caris Life Sciences, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
CAI Moving Averages Analysis
CAI (Caris Life Sciences, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Feb 03, 2026
| Days | MA |
|---|---|
| 10 | 24.89 |
| 20 | 26.07 |
| 30 | 26.6 |
| 50 | 26.58 |
| 100 | 28.26 |
| 200 | None |
CAI Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 7.9 billion |
| Earnings/Share ($) | -1.25 |
| Net Proft Margin (%) | -0.6043 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 0 |
| EPS Estimate Next Year ($) | 0 |
| WallStreet Target Price ($) | -- |
| Most Recent Quarter |